Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
XBI
120
HOLDINGS
12%
ALSO IN IBRN
IBRN
60
HOLDINGS
36%
ALSO IN XBI
SECTOR DRIFT (XBI minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 2.0% | 4.3% | 2.0% |
|
NEUROCRINE BIOSCIENCES INC | 1.6% | 3.4% | 1.6% |
|
PTC THERAPEUTICS INC | 1.6% | 4.8% | 1.6% |
|
SCHOLAR ROCK HOLDING CORP. | 1.1% | 4.5% | 1.1% |
 |
ALKERMES PLC | 1.0% | 3.3% | 1.0% |
XBI Overweight Relative to IBRN
|
EXACT SCIENCES CORP | 2.9% |
|
REVOLUTION MEDICINES, INC. | 2.5% |
|
AVIDITY BIOSCIENCES INC | 2.4% |
|
INSMED INC | 2.2% |
|
REGENERON PHARMACEUTICALS | 2.2% |
|
NATERA INC | 2.2% |
|
BRIDGEBIO PHARMA, INC. | 2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.0% |
|
AMGEN INC | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.9% |
XBI Underweight Relative to IBRN
 |
ARGENX SE ADR | -4.3% |
|
AXSOME THERAPEUTICS, INC. | -4.2% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.6% |
|
SUPERNUS PHARMACEUTICALS INC | -3.4% |
|
SCHOLAR ROCK HOLDING CORP. | -3.3% |
|
PTC THERAPEUTICS INC | -3.2% |
|
CATALYST PHARMACEUTICAL PART | -3.2% |
|
DENALI THERAPEUTICS INC. | -2.8% |
|
DYNE THERAPEUTICS INC | -2.6% |
|
EDGEWISE THERAPEUTICS, INC. | -2.6% |